Search

everythinglearnresearchcommunity

for

Search:↓

The treatment helped reduce symptoms and stabilize the hairline in most patients with Frontal Fibrosing Alopecia, but hair regrowth was limited.

Various dermatologic treatments were effective for skin conditions like acne, rosacea, hair loss, and psoriasis from December 1986 to December 1987.

Tofacitinib helped regrow hair in a lupus patient with alopecia.

Hair dye ingredient PPD can cause severe allergic reactions, including facial swelling.

Cortisone tapering may help improve severe myasthenia gravis and alopecia areata after thymectomy.

Calcipotriol is the safest and most effective for hair regrowth in localized alopecia areata.

Oral tofacitinib effectively regrows hair in children with alopecia areata without major side effects.

Platelet-rich plasma treatment is not very effective for chronic severe alopecia areata.

Tofacitinib helps regrow hair in severe alopecia patients, but more research is needed.

Tofacitinib effectively reduces hair loss in children with alopecia areata but may cause mild side effects and relapses.

Measuring bald patch size can help grade hair loss severity, with photograph-based evaluation being more reliable.

Tofacitinib effectively treated severe hair loss in a patient who didn't respond to other treatments.

Combining DPCP with PRP doesn't improve hair regrowth in alopecia areata.

Long-term use of difluprednate eye drops in dogs can lead to hair loss and hormone imbalance.

A personalized treatment combining traditional and new therapies may improve hair loss outcomes in alopecia areata.

A rare autoimmune disease caused the woman's scalp blisters and hair loss, successfully treated with medication.

Alopecia areata treatment varies, with no optimal method established yet.

Sarcoidosis can cause severe high calcium levels, hair loss, and kidney failure.

Abrocitinib helped a 14-year-old girl with severe alopecia areata regrow her hair significantly.

Methotrexate and vitamin D3 are potentially more effective and safer than triamcinolone for treating localized alopecia areata.

Lichen planus is a skin condition that can resolve on its own, is linked to hepatitis C, and increases the risk of skin cancer.

The document concludes that while there are various treatments for Alopecia Areata, there is no cure, and individualized treatment plans are essential due to varying effectiveness.

Guidelines suggest various treatments for alopecia areata, but leaving it untreated is also an option as 80% cases may recover on their own.

The pseudo 'fringe sign' can also appear in frontal fibrosing alopecia, not just in traction alopecia, showing that this condition may be more common than thought.

Baricitinib and deuruxolitinib are effective for treating alopecia areata, but their efficacy depends on the dose.

Henna has potential health benefits and can treat various conditions, but more research is needed to confirm safety and effectiveness.

Tofacitinib is a promising treatment for children with rheumatic diseases.

Methotrexate with steroids is slightly more effective than azathioprine with steroids for treating severe alopecia areata.

The document concludes that various skin conditions have specific treatments, ranging from antihistamines for urticaria to surgery and medication for tumors and chronic skin diseases.

JAK inhibitors show promise for treating alopecia areata but have serious side effects.